Get In Touch
  • Fb-icon
  • Top-linkdin
  • Top-twitter
  • Rss
Current Issue

animation-neutral-tts-300x100' width='300' height='100' border='0


Waters Introduces Solution for Mass and Purity Analysis of Biomolecules

New Intact Mass software application on waters_connect enables simplified and significantly faster analysis of biomolecules for mass and purity

Published : 21, Apr 2022

Waters Corp tops Human Rights Campaign Foundation’s CE Index

This recognition earns Waters designation as one of the Best Places to Work for LGBTQ+ Equality

Published : 28, Jan 2022

Waters Corporation Appoints Wei Jiang to Board of Directors

Waters Corporation has announced the appointment of Wei Jiang to its Board of Directors, effective July 14, 2021. Mr. Jiang currently serves as Executive Vice President and President,...

Published : 2, Jul 2021

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO)

Waters Corporation has introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method...

Published : 3, Jun 2021

Waters Corporation appoints Pearl S. Huang to Board of Directors

Currently serves on the boards of Cygnal Therapeutics and KSQ Therapeutics.

Published : 21, Dec 2020

Waters Corporation announces CFO transition

Michael Silveira Appointed Interim CFO, Effective January 1, 2021

Published : 7, Dec 2020

Waters Corporation names Udit Batra President & CEO

Dr. Batra succeeds Christopher O’Connell

Published : 4, Aug 2020

Waters to acquire Andrew Alliance

Waters enables core product portfolio with next-generation automation technology.  

Published : 14, Jan 2020